Burdenko Neurosurgery Institute
7
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Spontaneous Correction of Sagittal Imbalance After Isolated Lumbar Decompression
Role: collaborator
Sitting Versus Horizontal Position on Craniotomies
Role: collaborator
Hyperglycemia in Neurosurgery
Role: collaborator
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Role: collaborator
Safety and Efficiency of Combined Extracorporeal Blood Purification in Neurosurgical ICU. Prospective RCT
Role: lead
Impact of Severe Intraoperative Hyperglycemia on Infection Rate After Elective Intracranial Interventions
Role: lead
Nimotuzumab in Children With Intrinsic Pontine Glioma
Role: collaborator
All 7 trials loaded